Iovance Biotherapeutics, Inc. (IOVA)
14.22
-0.02
(-0.11%)
USD |
NASDAQ |
Oct 02, 16:00
14.22
+0.01
(+0.07%)
After-Hours: 20:00
Iovance Biotherapeutics Total Return Level : 14.22 for Oct. 2, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 02, 2026 | 14.22 |
| October 01, 2026 | 14.23 |
| September 30, 2026 | 14.82 |
| September 29, 2026 | 14.45 |
| September 28, 2026 | 10.99 |
| September 25, 2026 | 11.00 |
| September 24, 2026 | 10.80 |
| September 23, 2026 | 10.19 |
| September 22, 2026 | 10.64 |
| September 21, 2026 | 10.19 |
| September 18, 2026 | 10.25 |
| September 17, 2026 | 10.02 |
| September 16, 2026 | 9.87 |
| September 15, 2026 | 9.36 |
| September 14, 2026 | 9.26 |
| September 11, 2026 | 8.60 |
| September 10, 2026 | 8.14 |
| September 09, 2026 | 8.43 |
| September 08, 2026 | 8.70 |
| September 04, 2026 | 8.79 |
| September 03, 2026 | 8.70 |
| September 02, 2026 | 8.62 |
| September 01, 2026 | 8.28 |
| August 31, 2026 | 8.17 |
| August 28, 2026 | 8.01 |
| Date | Value |
|---|---|
| August 27, 2026 | 8.26 |
| August 26, 2026 | 8.08 |
| August 25, 2026 | 8.44 |
| August 24, 2026 | 8.06 |
| August 21, 2026 | 8.29 |
| August 20, 2026 | 8.99 |
| August 19, 2026 | 7.99 |
| August 18, 2026 | 7.03 |
| August 17, 2026 | 7.10 |
| August 14, 2026 | 6.98 |
| August 13, 2026 | 6.52 |
| August 12, 2026 | 6.74 |
| August 11, 2026 | 6.49 |
| August 10, 2026 | 6.40 |
| August 07, 2026 | 6.34 |
| August 06, 2026 | 6.21 |
| August 05, 2026 | 4.34 |
| August 04, 2026 | 4.36 |
| August 03, 2026 | 4.315 |
| July 31, 2026 | 4.07 |
| July 30, 2026 | 4.69 |
| July 29, 2026 | 4.56 |
| July 28, 2026 | 4.70 |
| July 27, 2026 | 4.90 |
| July 24, 2026 | 4.99 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AVITA Medical, Inc. | 12.72 |
| Amgen, Inc. | 603.52 |
| Halozyme Therapeutics, Inc. | 109.86 |
| Neurocrine Biosciences, Inc. | 143.18 |
| Editas Medicine, Inc. | 2.62 |